Prognostic Factors in Renal Cancer

  • B. van der Werf-Messing
  • R. O. van der Heul
  • R. Ch. Ledeboer
Part of the NATO Advanced Science Institutes Series book series (NSSA, volume 53)


In 1965, Rotterdam urologists and the Rotterdam Radiotherapy Institute started a prospective clinical trial in order to investigate the value of preoperative irradiation in renal cell cancer, to assess the value of the TNM classification of the International Union against Cancer, and to identify prognostic tumor and host factors. In a previous report, preliminary results have been reported (1).


Sedimentation Rate Renal Vein Renal Cancer Preoperative Irradiation Postoperative Score 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    B. van der Werf-Messing, Carcinoma of the kidney, Cancer 32: 1056 (1973).PubMedCrossRefGoogle Scholar
  2. 2.
    Union Internationale Contre le Cancer (UICC), TNM Classification of Malignant Tumours (2nd ed.), Geneva (1974), p. 75.Google Scholar
  3. 3.
    J. Berkson and R.P. Gage, Calculation of survival rates for cancer, Proc. Mayo Clinic 25: 270 (1950).Google Scholar
  4. 4.
    O. Arner, C. Blanck, and T. von Schreeb, Renal adenocarcinoma. Morphology, grading and malignancy, prognosis; a study of 197 cases, Acta Chir. Scand. Suppl. 346: 25 (1965).Google Scholar
  5. 5.
    L.E. Böttiger, Prognosis in renal carcinoma, Cancer 26: 780 (1970).PubMedCrossRefGoogle Scholar
  6. 6.
    E. Riches, Clinical features, in: “Tumours of the Kidney and Ureter, Vol. 5,” E. Riches, ed., E. & S. Livingstone Ltd., Edinburgh and London (1964), p. 137.Google Scholar
  7. 7.
    H.J.G. Bloom, Hormone treatment of renal tumours: Experimental and clinical observations, in: “Tumours of the Kidney and Ureter, Vol. 5,” E. Riches, ed., E. & S. Livingstone Ltd., Edinburgh and London (1964), p. 311.Google Scholar
  8. 8.
    B. van der Werf-Messing and H.A. van Gilse, Hormonal treatment of metastases of renal carcinoma, Br. J. Cancer 25: 423 (1971).PubMedCrossRefGoogle Scholar
  9. 9.
    W.C.J. Hop and B. van der Werf-Messing, Prognostic indexes for renal cell carcinoma, Eur. J. Cancer 16: 833 (1980).PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1983

Authors and Affiliations

  • B. van der Werf-Messing
    • 1
  • R. O. van der Heul
    • 1
  • R. Ch. Ledeboer
    • 1
  1. 1.Rotterdam Radiotherapy InstituteRotterdamHolland

Personalised recommendations